Recent developments in idiopathic intracranial hypertension (IIH)

Seminars in Ophthalmology

Volumn 18, Issue 4, 2003, Pages 181-189

  Goodwin, James ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDUCENS NERVE PARALYSIS; CEREBROSPINAL FLUID DRAINAGE; DECOMPRESSION SURGERY; FENESTRATION; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; OBESITY; OPTIC NERVE; OPTIC NERVE ATROPHY; OTITIS MEDIA; PAPILLEDEMA; PATHOGENESIS; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TINNITUS; VISUAL IMPAIRMENT;

HUMANS; INTRACRANIAL HYPERTENSION; OPHTHALMOLOGY;

EID: 4143049308     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1080/08820530390895181     Document Type: Review

References (73)

1. Davidoff LM. Pseudotumor cerebri. Neurology. 1956;6:605-615.
2. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155-180.
3. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875-877.
4. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33:1386-1388.
5. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 11-262002;59:1492-1495.
6. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: A case-control study in a headache center. Neurology. 1998;51:245-249.
7. Spence JD, Amacher AL, Willis NR. Benign intracranial hypertension without papilledema: role of 24-hour cerebrospinal fluid pressure monitoring in diagnosis and management. Neurosurgery. 1980;7:326-336.
8. Quincke H. Ueber meningitis serosa und verwandte zustande. Dtsch Z Nervenheilkd. 1897;9:149-168.
9. von Graefe A. Ueber complication von schnervenentzuendung mit gehirnkrankheiten. Arch Ophthalmol. 1860;7:58-71.
10. Allbutt TC. On the use of the ophthalmoscope in diseases of the nervous system and of the kidneys; also in certain other general disorders. New York: Macmillan; 1871.
11. Nonne M. Uber Falle von Symptomenkomplex "tumor cerebri" mit Ausgang in Heilung (Pseudotumor cerebri). Uber letal verlaufene Falle von "Pseudotumor cerebri" mit Sektionsbefund. Zeitschrift fur Nervenheilkunde. 1904;27: 169-216.
12. Johnston I. The historical development of the pseudotumor concept. Neurosurg Focus. 2001;11:1-9.
13. Passot R. Meningites et etats meninges aseptiques d'origine otique. These de Paris, G. Steinheil; 1913.
14. Dandy WE. Ventriculography following the injection of air into the cerebral ventricles. Ann Surg. 1918;68:5-11.
15. Dandy WE. Roentgenography of the brain after the injection of air into the spinal canal. Ann Surg. 1919;70:397-403.
16. Muller J, Hermes M, Piepgras U. Adolf Bingel, the second inventor of lumbar pneumencephalography. AJNR Am J Neuroradiol. 1995;16:487-490.
17. Bingel A. Encephalographie, eine methode zur roentgenographischen darstellung des gehirns. Forschr Geb Roentgenstr Nuklearmed Erganzungsband. 1921;28:205-217.
18. Symonds CP. Otitic Hydrocephalus. Brain. 1931;54:55-71.
19. Gardner WJ. Otitic sinus thrombosis causing intracranial hypertension. Arch Otolaryngol. 1939;30:253-268.
20. Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rail DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966;25:430-436.
21. Weiss MH, Nulsen FE. The effect of glucocorticoids on CSF flow in dogs. J Neurosurg. 1970;32:452-458.
22. Davidoff LM, Dyke CG. Hypertensive meningeal hydrops: Syndrome frequently following infection in middle ear or elsewhere in body. Am J Ophthalmol. 1937;20:908-927.
23. Dandy WE. Intracranial pressure without brain tumor: Diagnosis and Treatment. Ann Surg. 1937;106:492-513.
24. McAlpine D. Toxic hydrocephalus. Brain. 1937;60:180-203.
25. Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology. 1956;6:791-803.
26. Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol. 1995;52:141-145.
27. Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974;97:301-312.
28. Bercaw BL, Greer M. Transport of intrathecal 131-I risa in benign intracranial hypertension. Neurology. 1970;20:787-790.
29. Hayes KC, McCombs HL, Faherty TP. The fine structure of vitamin A deficiency. II. Arachnoid granulations and CSF pressure. Brain. 1971;94:213-224.
30. Feldman MH, Schlesinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol. 1970;22:l-7.
31. Walker AE, Adamkiewicz JJ. Pseudotumor cerebri associated with prolonged corticosteroid therapy: report of four cases. JAMA. 1964;188:799-784.
32. Neville BG, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J. 9-5-1970;3:554-556.
33. Evans MG. Bilateral jugular vein ligation following bilateral suppurative mastoiditis. Ann Otol Rhinol Laryngol. 1942;51:615-625.
34. Johnston I. The definition of reduced CSF absorption syndrome: a reapraisal of benign intracranial hypertension and related conditions. Med Hypotheses. 1975;1:10-14.
35. Risberg J, Lundberg N, Ingvar DH. Regional cerebral blood volume during acute transient rises of the intracranial pressure (plateau waves). J Neurosurg. 1969;31:303-310.
36. Czosnyka M, Whitehouse H, Smielewski P, Simac S, Pickard JD. Testing of cerebrospinal compensatory reserve in shunted and non-shunted patients: A guide to interpretation based on an observational study. J Neurol Neurosurg Psychiatry. 1996;60:549-558.
37. Higgins JN, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 1-19-2002;359:228-230.
38. King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224-2228.
39. Ray BS, Dunbar HS. Thrombosis of the dural venous sinuses as a cause of "pseudotumor cerebri". Ann Surg. 1951;134:367-386.
40. Iwabuchi T, Sobata E, Suzuki M, Suzuki S, Yamashita M. Dural sinus pressure as related to neurosurgical positions. Neurosurgery. 1983;12:203-207.
41. Ekstedt J. CSF hydrodynamic studies in man. 2. Normal hydrodynamic variables related to CSF pressure and flow. J Neurol Neurosurg Psychiatry. 1978;41:345-353.
42. Mamourian AC, Towfighi J. MR of giant arachnoid granulation, a normal variant presenting as a mass within the dural venous sinus. AJNR Am J Neuroradiol. 1995;16:901-904.
43. Browder J, Kaplan HA, Howard EM. Hyperplasia of pacchionian granulations. Arch Pathol. 1973;95:315-316.
44. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology. 1996;46:198-202.
45. Sugerman HJ, Felton WL, Salvant JBJ, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45:1655-1659.
46. Sugerman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49:507-511.
47. Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229:634-640.
48. Sugerman HJ, Felton IW, III, Sismanis A, Saggi BH, Doty JM, Blocher C, Marmarou A, Makhoul RG. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Int J Obes Relat Metab Disord. 2001;25:486-490.
49. Kollar C, Parker G, Johnston I. Endovascular treatment of cranial venous sinus obstruction resulting in pseudotumor syndrome. Report of three cases. J Neurosurg. 2001;94:646-651.
50. Johnston I, Kollar C, Dunkley S, Assaad N, Parker G. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci. 2002;9:273-278.
51. King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002;58:26-30.
52. King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224-2228.
53. Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, TerBrugge KG. Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology. 5-13-2003;60:1418-1424.
54. King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224-2228.
55. Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rail DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966;25:430-436.
56. Neblett CR, McNeel DP, Waltz TA Jr, Harrison, GM. Effect of cardiac glycosides on human cerebrospinal fluid production. Lancet. 1972;1:358-359.
57. Anderrson K-E, Bertler A, Wettrell G. Post-mortem distribution and tissue concentrations of digoxin in infants and adults. Acta Paediatr Scand. 1975;64:497-504.
58. Bertler A, Andersson K-E, Wettrell G. Concentration of digoxin in choroid plexus. Lancet. 1973;2:1453-1454.
59. Schott GD, Holt D. Digoxin in benign intracranial hypertension. Lancet. 1974;1:358-359.
60. Weisberg L, Chutorian AM. Steroid therapy in refractory pseudotumor cerebri of childhood. Trans Am Neurol Assoc. 1975;100:253-256.
61. Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 7-15-1994;118:88-96.
62. Miller JD, Leech P. Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg. 1975;42:274-281.
63. Kessler LA, Novelli PM, Reigel DH. Surgical treatment of benign intracranial hypertension-subtemporal decompression revisited. Surg Neurol. 1998;50:73-76.
64. Burgert RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri [see comments]. Neurology. 1997;49:734-739.
65. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524-1530.
66. Tulipan N, Lavin PJ, Copeland M. Stereotactic ventriculoperitoneal shunt for idiopathic intracranial hypertension: Technical note. Neurosurgery. 1998;43:175-176.
67. DeWecker L. On incision of the optic nerve in cases of neuroretinitis. Int Ophthalmol Congr. 1872;4:14.
68. Paton L, Holmes G. The pathology of papilledema. A histological study of 60 eyes. Brain. 1935;33:119.
69. Taylor J. Optic neuritis in its relation to ultra-cranial tumour and trephining. Trans Ophthalmol Soc UK. 1893;14:105-118.
70. Hupp SL, Glaser JS, Frazier-Byrne S. Optic nerve sheath decompression. Review of 17 cases. Arch Ophthalmol. 1987;105:386-389.
71. Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988;106:1391-1397.
72. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Archives of Ophthalmology. 5-1-1993;111:632-635.
73. Spoor TC, McHenry JG, Shin DH. Long-term results using adjunctive mitomycin C in optic nerve sheath decompression for pseudotumor cerebri. Ophthalmology. 1995;102:2024-2028.